Published in J Virol on July 23, 2008
Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 3.70
A targeted spatial-temporal proteomics approach implicates multiple cellular trafficking pathways in human cytomegalovirus virion maturation. Mol Cell Proteomics (2009) 1.48
Spatial relationships between markers for secretory and endosomal machinery in human cytomegalovirus-infected cells versus those in uninfected cells. J Virol (2011) 1.32
Viral and host control of cytomegalovirus maturation. Trends Microbiol (2012) 1.15
Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol (2009) 1.09
Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells. J Virol (2010) 1.08
Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids. J Virol (2011) 1.05
Role of tegument proteins in herpesvirus assembly and egress. Protein Cell (2010) 1.02
The human cytomegalovirus (HCMV) tegument protein UL94 is essential for secondary envelopment of HCMV virions. J Virol (2011) 0.97
Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28). Virol J (2012) 0.94
Cytomegalovirus UL103 controls virion and dense body egress. J Virol (2011) 0.93
Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment. J Virol (2011) 0.92
A role for the small GTPase Rab6 in assembly of human cytomegalovirus. J Virol (2011) 0.91
Interaction between the human cytomegalovirus tegument proteins UL94 and UL99 is essential for virus replication. J Virol (2012) 0.89
The A, B, Cs of herpesvirus capsids. Viruses (2015) 0.88
Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment. J Virol (2014) 0.88
The tegument protein pp65 of human cytomegalovirus acts as an optional scaffold protein that optimizes protein uploading into viral particles. J Virol (2014) 0.86
Human cytomegalovirus tegument protein pp150 acts as a cyclin A2-CDK-dependent sensor of the host cell cycle and differentiation state. Proc Natl Acad Sci U S A (2013) 0.83
Nuclear targeting of human cytomegalovirus large tegument protein pUL48 is essential for viral growth. J Virol (2013) 0.81
Highly acidic C-terminal region of cytomegalovirus pUL96 determines its functions during virus maturation independently of a direct pp150 interaction. J Virol (2014) 0.79
Human Cytomegalovirus pUL93 Is Required for Viral Genome Cleavage and Packaging. J Virol (2015) 0.78
Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis. Virology (2013) 0.77
Human Cytomegalovirus pUL47 Modulates Tegumentation and Capsid Accumulation at the Viral Assembly Complex. J Virol (2015) 0.76
Role of human cytomegalovirus tegument proteins in virion assembly. Viruses (2014) 0.76
Murine cytomegalovirus IE3-dependent transcription is required for DAI/ZBP1-mediated necroptosis. EMBO Rep (2017) 0.75
Mouse cytomegalovirus M36 and M45 death suppressors cooperate to prevent inflammation resulting from antiviral programmed cell death pathways. Proc Natl Acad Sci U S A (2017) 0.75
Synthetic lethal mutations in the cyclin A interface of human cytomegalovirus. PLoS Pathog (2017) 0.75
Inhibition of endocytic pathways impacts cytomegalovirus maturation. Sci Rep (2017) 0.75
Improved retroviral vectors for gene transfer and expression. Biotechniques (1989) 19.48
Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A (2003) 5.21
Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci U S A (2003) 4.21
Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science (2002) 4.13
Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur J Cell Biol (1993) 3.46
A set of recombineering plasmids for gram-negative bacteria. Gene (2006) 3.45
Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology (1983) 3.32
Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. J Virol (2003) 2.72
Budding events in herpesvirus morphogenesis. Virus Res (2004) 2.71
Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J Virol (1998) 2.53
Structure and assembly of the virion. Intervirology (1996) 2.46
UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc Natl Acad Sci U S A (2000) 2.36
The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J Virol (2003) 2.21
Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology (1999) 2.20
Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci U S A (2001) 2.10
Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus. J Virol (1986) 2.09
The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J Virol (1995) 2.07
Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol (2004) 1.94
Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc Natl Acad Sci U S A (2000) 1.91
Recombineering: genetic engineering in bacteria using homologous recombination. Curr Protoc Mol Biol (2007) 1.86
Capsid structure of simian cytomegalovirus from cryoelectron microscopy: evidence for tegument attachment sites. J Virol (1999) 1.79
Three-dimensional structure of the human cytomegalovirus cytoplasmic virion assembly complex includes a reoriented secretory apparatus. J Virol (2007) 1.73
Identification of a 65 000 dalton virion envelope protein of human cytomegalovirus. Virus Res (1985) 1.63
Identification of the major capsid protein gene of human cytomegalovirus. J Virol (1989) 1.56
Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis. J Virol (2005) 1.51
Human cytomegalovirus labeled with green fluorescent protein for live analysis of intracellular particle movements. J Virol (2005) 1.49
Nuclear localization of the human cytomegalovirus tegument protein pp150 (ppUL32). J Gen Virol (1995) 1.47
Cytomegalovirus basic phosphoprotein (pUL32) binds to capsids in vitro through its amino one-third. J Virol (2001) 1.45
Common and specific properties of herpesvirus UL34/UL31 protein family members revealed by protein complementation assay. J Virol (2006) 1.34
Human cytomegalovirus morphogenesis: an ultrastructural study of the late cytoplasmic phases. Arch Virol (1988) 1.33
Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J Virol (2006) 1.30
Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog (2007) 1.29
An acidic cluster of human cytomegalovirus UL99 tegument protein is required for trafficking and function. J Virol (2004) 1.24
Sequence requirements for localization of human cytomegalovirus tegument protein pp28 to the virus assembly compartment and for assembly of infectious virus. J Virol (2006) 1.18
Complex formation by glycoproteins M and N of human cytomegalovirus: structural and functional aspects. J Virol (2005) 1.15
Structural changes in human cytomegalovirus cytoplasmic assembly sites in the absence of UL97 kinase activity. Virology (2006) 1.15
Cytoplasmic envelopment of human cytomegalovirus requires the postlocalization function of tegument protein pp28 within the assembly compartment. J Virol (2007) 1.10
The cytoplasmic tail of glycoprotein M (gpUL100) expresses trafficking signals required for human cytomegalovirus assembly and replication. J Virol (2007) 0.99
Structural components of human cytomegalovirus: in situ localization of the major glycoprotein. Intervirology (1987) 0.90
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 7.70
RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature (2011) 6.03
Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 3.70
DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe (2012) 3.23
Activation of innate immunity is required for efficient nuclear reprogramming. Cell (2012) 2.99
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med (2003) 2.75
Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem (2013) 2.24
Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol (2003) 2.03
Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol (2007) 1.97
Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol (2004) 1.94
Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem (2008) 1.78
Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner. J Immunol (2012) 1.71
Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol (2008) 1.66
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation (2004) 1.62
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation (2006) 1.46
Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol (2003) 1.44
Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J Virol (2005) 1.39
Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J Virol (2006) 1.30
Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog (2007) 1.29
Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1β via caspase-8 in dendritic cells. J Immunol (2013) 1.28
Viral modulation of programmed necrosis. Curr Opin Virol (2013) 1.20
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood (2003) 1.19
Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J Virol (2005) 1.16
Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood (2005) 1.15
Viral and host control of cytomegalovirus maturation. Trends Microbiol (2012) 1.15
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation (2006) 1.11
RNA analysis by biosynthetic tagging using 4-thiouracil and uracil phosphoribosyltransferase. Methods Mol Biol (2008) 1.09
Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol (2009) 1.09
Updated guidelines on the management of cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab. Clin Lymphoma Myeloma (2006) 1.09
Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes. Immunity (2012) 1.07
Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids. J Virol (2011) 1.05
HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog (2008) 1.00
The need and challenges for development of an Epstein-Barr virus vaccine. Vaccine (2013) 0.98
Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J Virol (2004) 0.97
Expression of human CXCR2 in murine neutrophils as a model for assessing cytomegalovirus chemokine vCXCL-1 function in vivo. J Interferon Cytokine Res (2004) 0.96
Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model. BMC Dev Biol (2006) 0.95
Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. J Immunol (2006) 0.94
Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels. Mol Immunol (2011) 0.92
Transcription of true late (γ2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses. J Virol (2013) 0.92
Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilin-dependent pathway specifically in neural stem/progenitor cells. J Virol (2007) 0.92
Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. J Clin Microbiol (2007) 0.92
Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes. J Virol (2013) 0.91
The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion (2009) 0.91
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients. PLoS One (2009) 0.90
Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood (2002) 0.90
Changes in coronary arterial dimensions early after cardiac transplantation. Transplantation (2007) 0.89
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. Circulation (2011) 0.89
Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA. J Virol (2005) 0.89
Manipulation of apoptosis and necroptosis signaling by herpesviruses. Med Microbiol Immunol (2015) 0.88
Antiviral T cell response triggers cytomegalovirus hepatitis in mice. J Virol (2012) 0.82
Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein. Virology (2008) 0.82
Inhibition of 2',5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product. J Virol (2011) 0.80
Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway. Virology (2012) 0.80
Highly acidic C-terminal region of cytomegalovirus pUL96 determines its functions during virus maturation independently of a direct pp150 interaction. J Virol (2014) 0.79
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus. Transplantation (2008) 0.79
Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. J Heart Lung Transplant (2007) 0.78
Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis. Virology (2013) 0.77
Mechanisms modulating immune clearance during human cytomegalovirus latency. Proc Natl Acad Sci U S A (2012) 0.75
Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. Clin Infect Dis (2008) 0.75
Cytomegalovirus and heart transplant atherosclerosis: a likely guilt hidden by weak proofs. Transplantation (2004) 0.75
[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome]. G Ital Cardiol (Rome) (2007) 0.75
Natural antisense transcripts of UL123 packaged in human cytomegalovirus virions. Arch Virol (2013) 0.75